What were the key takeaways from Herbalife's earnings call?

What is the revenue and EPS growth rate for Herbalife year over year?

What guidance did Herbalife's management provide for the next earnings period?

What were the key takeaways from Herbalife’s earnings call?

What is the market's earnings forecast for Herbalife next quarter?

Did Herbalife beat or miss consensus estimates last quarter?

What factors drove the changes in Herbalife's revenue and profit?

What is Herbalife's gross profit margin?

- **Revenue and Profit Growth**: Q4 net sales $1.3B (+6.3% YoY), full-year EBITDA $658M (+180bps margin). India sales up 15% YoY due to GST tax cut.
- **Digital Innovation**: Pro2col Beta 2.0 launched in U.S., with personalized supplements rolling out in 2026. $7.5M investment from Cristiano Ronaldo to accelerate digital health platform.
- **Distributor Network Strength**: Global new distributors up 16% on 2-year stack, 75% regions reporting growth. Nutrition Clubs expanded to 60,000 globally.
- **Financial Discipline**: Debt reduced by $283M in 2025, leverage ratio 2.8x. 2026 guided for 1-6% sales growth, $670-710M EBITDA.

**【CEO Summary Section】**
- **Revenue Growth and Profitability**: Q4 net sales of $1.3 billion (+6.3% YoY), full-year net sales of $5.1 billion (+1% YoY). Adjusted EBITDA of $156 million in Q4, full-year $658 million (+180bps margin expansion). India delivered record Q4 sales of $250 million (+15% YoY) due to GST tax reduction.
- **Product Innovation and Digital Transformation**: Launched MultiBurn, HL/Skin, and Life I/O Baseline. Pro2col Beta 2.0 rolled out in U.S., Canada, and Puerto Rico, with U.S. distributors gaining access to personalized supplements by mid-2026. Acquired Cristiano Ronaldo's 10% stake in Pro2col Software for $7.5 million, leveraging his global influence to enhance brand visibility.
- **Distributor Network Strength**: Global new distributors up 16% on a 2-year stack (North America +19%, Latin America +11%). Enhanced training, digital tools, and resources drove engagement, with 75% of regions reporting 2-year growth. Nutrition Clubs expanded to 60,000 globally.

**【CFO Financial Commentary】**
- **Financial Discipline**: Reduced total leverage to 2.8x from 3.9x in 2 years, repaid $283 million debt in 2025. Operating cash flow of $333 million (+17% YoY). Q4 gross profit margin 77.5%, pressured by FX and input costs but offset by pricing benefits.
- **Regional Performance**: Latin America (+18% YoY), EMEA (+9% YoY), Asia Pacific (+5% YoY). North America sales stable despite headwinds, expected to grow in 2026. China sales down 4% YoY due to volume decline, but improving execution.
- **2026 Outlook**: Guided for 1-6% YoY net sales growth, $670-710 million adjusted EBITDA. Capital expenditures $50-80 million, SaaS implementation costs $40-60 million. Tax rate expected at 30%.

**【Q&A Highlights】**
- **India Growth Sustainability**: GST tax reduction tailwind to persist until Q3 2026, with India expected to remain a key growth driver. 
- **Pro2col Contribution**: Minimal top-line impact in 2026, but potential upside from beta testing in EMEA. 
- **Margin Expansion**: 20-30bps margin expansion driven by cost control, despite $16 million annualized GST-related expense in India. 
- **Product Category Momentum**: Energy/sports nutrition category outperformed, with MultiBurn and Baseline launches contributing to 2-year growth trends.

Herbalife Ltd. (HLF) Q4 2025 Earnings Call Transcript

- **Revenue Turnaround**: North America and worldwide net sales growth (1% and 2.7% YoY) after years of decline.
- **Pro2col Beta Success**: 7,900 distributors logged 32M steps and 200K product schedules, with AI features driving engagement.
- **Debt Reduction**: Leverage ratio at 2.8x (vs. target 3x), with $147M debt repayment in Q3.
- **Personalized Supplements**: Link BioScience to launch in U.S. in H1 2026, enabling formulated supplements.
- **Distributor Growth**: North America up 17% YoY, global 2-year stacked growth 11%.

**【CEO Summary Section】**
- **Net Sales Growth**: Returned to year-over-year growth in North America (1% YoY) and worldwide (2.7% YoY), marking the first quarterly increase in North America since Q2 2021.
- **Pro2col Beta Success**: 7,900 distributors in the beta group logged 32 million steps, 200,000 product usage schedules, and 36,000 meals, with AI features like the food scanner proving popular.
- **Personalized Supplements**: Link BioScience will enable formulated supplements tailored to individual needs, launching in the U.S. in H1 2026.
- **Distributor Momentum**: North America saw 17% new distributor growth, while global distributor growth declined 2% YoY (but up 11% on a 2-year stacked basis).
- **Events & Engagement**: 57,000 attendees at Q3 Extravaganzas, a 5% increase in global attendance vs. 2024, with EMEA up 25% YoY.

**【CFO Financial Commentary】**
- **Q3 Financials**: Net sales $1.3B (2.7% YoY), Adjusted EBITDA $163M (exceeded guidance), and $139M operating cash flow.
- **Debt Reduction**: Fully repaid $147M in 2025 notes, reducing leverage to 2.8x (target 3x by end-2025).
- **Margins**: Gross profit margin 77.7% (down 60 bps YoY due to FX and input costs), Adjusted EBITDA margin 12.8% (down 60 bps YoY).
- **Guidance**: Q4 net sales growth 1.5-5.5% YoY, full-year net sales 0-0.7% YoY.

**【Q&A Highlights】**
- **Capital Allocation**: Prioritize debt reduction (target $1.4B by 2028) over buybacks; no immediate plans for stock repurchases.
- **Pro2col Expansion**: Commercial launch in U.S. by year-end, with beta access expanded to retail customers.
- **Skin Care Growth**: HL/Skin launched in EMEA with 11-month development, generating strong distributor engagement and plans for global expansion.
- **Subscription Potential**: Multiburn and personalized supplements could drive subscription revenue, with Pro2col enabling recurring sales through AI-driven recommendations.
- **China Challenges**: Net sales down 5% YoY due to volume decline, but focus on long-term strategy and distributor engagement.

Herbalife Ltd. (HLF) Q3 2025 Earnings Call Transcript

- **Q2 Recovery Signs**: North America volume growth in July, signaling turnaround after 4 years of decline.
- **Innovation Momentum**: Pro2col beta engagement surpasses expectations, with 7,000+ distributors opting in.
- **Financial Resilience**: EBITDA margin of 13.8% despite FX headwinds, $55M debt reduction.
- **Subscription Growth**: MultiBurn sales outperforming expectations, setting stage for recurring revenue.
- **Strategic Integration**: Link Biosciences to enable personalized supplements, expanding into global markets in 2026.

**【CEO Summary Section】**
- **Q2 Financials**: Net sales of $1.3 billion, down 1.7% YoY, flat on a constant currency basis. Adjusted EBITDA exceeded guidance at $174 million, with a 13.8% margin.
- **North America Recovery**: July marked the first year-over-year volume growth in North America since April 2021, driven by MultiBurn and Pro2col beta launches.
- **Product Innovations**: Launched MultiBurn (non-pharmaceutical weight loss supplement) and a healthy lifespan supplement with Niagen. Pro2col beta engaged 7,000 distributors, with a Q4 commercial launch planned.
- **Strategic Integrations**: Integrated Link Biosciences for personalized supplements, targeting 2026 global expansion. Acquired Pruvit assets, with 400 distributors joining the Pro2col beta.
- **Updated Guidance**: Full year net sales guidance narrowed to down 1% to up 3% YoY, reflecting confidence in Q3 growth (0.5%-4.5% YoY).

**【CFO Financial Commentary】**
- **Financial Strength**: $96 million operating cash flow, $55 million debt repayment, maintaining 3x leverage ratio. Adjusted EBITDA margin of 13.8%, down 30bps YoY due to FX.
- **Regional Performance**: Latin America (+9% local currency), North America (-4% YoY but improving sequentially), Asia Pacific (-1% YoY), China (-2% YoY).
- **FX Impact**: 170bps headwind YoY, better than expected due to dollar weakening. Full year tax rate expected at 27%-28%.
- **CapEx Optimization**: Reduced 2025 CapEx to $75-95 million, focusing on technology spend.

**【Q&A Highlights】**
- **Pro2col Monetization**: Subscription model with blended pricing, similar to existing products. Distributors can use Pro2col as a tool or launch new premium programs.
- **Subscription Strategy**: MultiBurn and healthy lifespan supplement will be offered via auto-replenishment, with early sales exceeding expectations.
- **Pricing Strategy**: Limited price increases to maintain value proposition, supported by digital tools like Pro2col.
- **Global Expansion**: Pro2col to launch in additional markets starting 2026, with Link Biosciences integration driving personalized solutions.


Herbalife Ltd. (HLF) Q2 2025 Earnings Call Transcript

- **Digital Health Platform Expansion**: Pro2col beta launch in July 2025, targeting 100K+ users by year-end. Integrates AI, personalized products, and global distributor network.
- **Financial Resilience**: Q1 2025 adjusted EBITDA beats guidance by $15M. Total leverage ratio reduced to 3x, debt repayment ahead of schedule.
- **Market Momentum**: New distributor growth +16% YoY. North America volumes expected to improve sequentially; India (+3% YoY) and China (-14% YoY) show divergent trends.
- **Strategic Investments**: $25.5M paid for acquisitions, with contingent payments tied to Pro2col commercial launch. Full year 2025 EBITDA guidance raised to $625-655M.
- **Risk Management**: Tariff impact minimal ($10-15M annualized). Currency headwinds reduced to $150M net sales impact vs. prior $200M estimate.


**【CEO Summary Section】**
- **Strategic Acquisitions**: Completed acquisitions of Pro2col, Pruvit, and Link BioSciences to enhance digital health platform and personalized product offerings. Pro2col platform beta launch in July 2025, commercial release in Q4 2025.
- **Revenue Performance**: Q1 2025 net sales $1.2B (-3.4% YoY, +1.4% constant currency). Adjusted EBITDA $165M (+260bps margin YoY). Distributor growth: +16% YoY new distributors, 45th consecutive quarter of growth.
- **Financial Strength**: Total leverage ratio reduced to 3x (target met 9 months ahead of plan). Debt repayment of $70M in Q1, with $1.4B debt reduction target by 2028.
- **Market Momentum**: North America volumes down 8% YoY but sequential improvement expected. India net sales +3% YoY, China down 14% YoY due to macro challenges.

**【CFO Financial Commentary】**
- **Profitability**: Gross margin 78.3% (+80bps YoY). Adjusted EBITDA $165M vs. guidance $140-150M. Operating cash flow neutral due to annual bonuses and distributor payouts.
- **Liquidity**: Cash balance $329M. Undrawn revolving credit facility. Capital expenditures $18M (below $30-40M guidance) due to project delays.
- **Guidance Update**: Full year 2025 net sales -2.5% to +2.5% YoY (constant currency: +0.5% to +5.5%). Adjusted EBITDA $625-655M (+$25M from prior guidance). Tax rate 28-30%.

**【Q&A Highlights】**
- **Pro2col Monetization**: Early beta testing in North America, targeting 100K+ users by end-2025. Revenue streams include app subscriptions, personalized products, and new distributor recruitment.
- **China Challenges**: Regulatory uncertainty and macro weakness impacting sales. Focus on long-term engagement through digital tools and distributor training.
- **Asia Pacific Growth**: India driving regional growth (+7% local currency). Korea and Indonesia face short-term headwinds but structural strength remains.
- **Tariff Impact**: 2025 tariffs estimated $10-15M annualized, non-material to results. Currency headwinds reduced to $150M net sales impact vs. prior $200M estimate.


Herbalife Nutrition (HLF)-30 Apr 25-2025 Q1 Earnings call transcript

- **Leadership transition**: Stephan Gratziani becomes CEO, Rob Levy leads Worldwide Markets, signaling distributor-centric strategy.
- **Financial resilience**: Q4 adjusted EBITDA +38% margin expansion, $250M debt reduction, 3.2x leverage ratio.
- **Distributor momentum**: New distributors +22% Q4 YoY, active non-sales leaders +10% full year YoY, sales leader retention +200bps.
- **2025 outlook**: Constant currency net sales +1% to +7%, EBITDA margin >13% (excluding FX).

**【CEO Opening Remarks】**
- Announced Stephan Gratziani as CEO effective May 1, 2025, and Rob Levy as President of Worldwide Markets.
- Q4 net sales: $1.2 billion (down 0.6% YoY reported, +2.7% constant currency). Full year net sales: $5 billion (-1.4% YoY reported, +1.2% constant currency).
- Q4 adjusted EBITDA: $150 million (+38% YoY margin improvement). Full year adjusted EBITDA: $635 million (+$64 million YoY).
- Debt reduction: $250 million in 2024, total leverage ratio down to 3.2x from 3.9x.
- Distributor trends: New distributors +22% Q4 YoY, active non-sales leaders +10% full year YoY, sales leader retention rate +200 basis points YoY.

**【CFO Financial Update】**
- Q4 gross profit margin: 77.8% (+150 basis points YoY).
- 2025 guidance: Net sales -3% to +3% YoY (constant currency +1% to +7%). Adjusted EBITDA: $600M-$640M (constant currency $670M-$710M).
- FX headwinds: ~$200M net sales impact, ~$70M EBITDA impact.
- Capital expenditures: $100M-$130M for 2025.

**【Q&A Key Takeaways】**
- **North America recovery**: Distributor metrics improving, net sales down 3% Q4 YoY (vs. -10%+ in prior quarters). Expecting growth in 2025.
- **China strategy**: Transitioning to customer-centric model, 2024 net sales -20% YoY, focusing on loyalty programs and leadership training.
- **Debt management**: Plan to repay $200M of 2025 notes, targeting 3x leverage by end-2025.
- **Tariff risks**: Minimal direct exposure, but monitoring potential retaliatory tariffs in Mexico.
- **Digital transformation**: Investing in SaaS and tools to support distributors' growth.


Actual											0.83	0.95	1.15	0.71	1.42	1.52	1.21	0.57	0.99	0.96	0.91	0.53	0.54	0.74	0.65	0.28	0.49	0.54	0.57	0.36	0.59	0.59	0.5	0.45
Forecast											0.593	0.8595	0.8763	0.838	1.088	1.2948	1.0561	0.6404	0.9208	0.7402	0.7954	0.3376	0.6551	0.6895	0.7301	0.3958	0.3782	0.4131	0.3107	0.1896	0.4072	0.4975	0.4612	0.4766
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+39.97%	+10.53%	+31.23%	-15.27%	+30.51%	+17.39%	+14.57%	-10.99%	+7.52%	+29.69%	+14.41%	+56.99%	-17.57%	+7.32%	-10.97%	-29.26%	+29.56%	+30.72%	+83.46%	+89.87%	+44.89%	+18.59%	+8.41%	-5.58%

HLF

HLF fundamentals

HLF Q4 2025 Earnings

Earnings Call

You can ask Aime

HLF

HLF fundamentals

HLF Q4 2025 Earnings

Earnings Call

HLF Earnings Call Summary for Q4/20255:30 PM on Feb 18, 2026

HLF Earnings Call Summary for Q3/20255:30 PM on Nov 5, 2025

HLF Earnings Call Summary for Q2/20255:30 PM on Aug 6, 2025

HLF Earnings Call Summary for Q1/20255:30 PM on Apr 30, 2025

HLF Earnings Call Summary for Q4/20245:30 PM on Feb 19, 2025

You can ask Aime